Doximity's AI Push: Record Revenue, Engagement

Doximitys Q4 and FY Results: Record Revenue, AI Push, and Strategic Hires Doximitys Q4 and full fiscal year results exceeded expectations, with $145 million in revenue, a 5% increase from last year, and $645 million for the year, a 13% jump. Free cash flow reached a record $107 million in Q4 and $317 million for the year, up 19%. Adjusted EBITDA margins remained strong at 45% in Q4 and 55% annually. The company is investing heavily in AI, with workflow tools now reaching nearly half of US doctors at buying hospitals. AI search and scribe users tripled since acquiring Pathway, with over two hundred fifty thousand prescribers now accessing AI features. Doctors and pharma are impressed, with AI beating top competitors in head-to-head tests and early deals with big players. Doximitys guidance reflects a cautious market, with Q1 fiscal 2027 revenue projected at $151-152 million, a 4% growth midpoint, and full-year outlook at $664-676 million, also a 4% midpoint. Adjusted EBITDA margins are expected to be around 49%. The company is ramping up AI spend on R&D and compute, expecting minimal AI revenue this year but aiming for multibillion-dollar potential long-term. Doximity is positioning itself as the go-to physician network and top AI platform, with record engagement and new tools like e-prescribing and value-based care agents. Theyre betting on doctor trust to outpace the market as budgets loosen up. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/31657e0445a14ca6